期刊文献+

基质金属蛋白酶检测对鉴别化脓性脑膜炎与病毒性脑炎的价值 被引量:3

Value of Detecting Matrix Metalloproteinases Levels for Differential Diagnosis between Purulent Meningitis and Viral Encephalitis in Children
在线阅读 下载PDF
导出
摘要 目的通过对血清和脑脊液(CSF)基质金属蛋白酶(MMPs)水平检测,探讨其对小儿化脓性脑膜炎(化脑)与病毒性脑炎(病脑)的鉴别诊断价值。方法采用ELISA法检测18例化脑及22例病脑患儿急性期血清和CSF中MMP-2、MMP-9水平,并与正常对照组比较。结果化脑、病脑患儿血清和CSF中MMP-2、MMP-9水平显著高于正常对照组(P<0.001),且化脑组显著高于病脑组(P<0.001)。结论血清和CSF中MMP-2、MMP-9检测,对小儿化脑与病脑有早期诊断和鉴别诊断价值,为临床尽早用药提供实验室依据。 Objective To obtain early diagnosis and differential diagnosis of purulent meningitis(PM) from viral encephalitis(VE) in children through determination of matrix metalloproteinases(MMPs) levels in serum and cerebrospinal fluid(CSF). Methods The levels of MMP - 2 and MMP - 9 in serum and CSF were determined by enzyme linked immunosorbent assay(ELISA) in 18 children with PM in acute phase, 22 children with VE in acute phase, and 20 normal children. Results The levels of MMP - 2 and MMP - 9 in ,serum and CSF in children with PM and VIE were significantly higher than those in controls( P〈0. 001 ), and the levels in children with PM were significantly higher than those in children with VE ( p 〈 0. 001 ). Conclusion Determination of MMP - 2 and MMP - 9 levels could provide a reliable means of early diagnosis and differential diagnosis of PM from VE in children and proper treatment might be earlier implemented.
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2006年第21期1500-1501,共2页 Journal of Applied Clinical Pediatrics
关键词 基质金属蛋白酶类 儿童 脑膜炎 化脓性 脑炎 病毒性 诊断 鉴别 matrix metalloproteinase child purulent meningitis encephalitis, viral diagnosis, differential
作者简介 刘俊英,女,副主任医师,硕士学位,研究方向为神经系统疾病。
  • 相关文献

参考文献11

二级参考文献82

  • 1陈德容,卢淑玲,蔡任军.颅内感染血和脑脊液C-反应蛋白检测的临床意义[J].国际医药卫生导报,2004,10(12):148-149. 被引量:9
  • 2赵永新,李倩,张莉.C-反应蛋白、中性粒细胞碱性磷酸酶、白细胞、中性粒细胞、血沉等指标在感染性疾病中的应用[J].实用儿科临床杂志,2005,20(3):282-283. 被引量:25
  • 3各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33150
  • 4Stuve O, Dooley NP, Uhm JH, et al. Interferon beta-1b decreases the migration of T lymphocytes in vitro:effects on matrix metalloproteinase-9[ J]. Ann Neurol, 1996,40(6) : 853-863.
  • 5Romanic AM, White RF, Arieth A J, et al. Matrix metalloproteinase expression increases after focal ischemia in rats:inhibition of matrix metalloproteinase-9 reduces infarct size [ J ]. Stroke, 1998, 29 ( 5 ) : 1020-1030.
  • 6Gasche Y, Fujimura M, Morita-Fujimura Y, et al. Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice:a possible role in blood-brain barrier dysfunction[J] .J Cereb Blood Flow Metab, 1999,19(9) : 1020-1028.
  • 7Heo JH, Lucero J, Abumiya T, et al. Matrix metalloproteinases increase very early during experimental focal cerebral ischemia [ J ]. J Cereb Blood Flow Metab, 1999,19(6) :624-633.
  • 8Rosenberg GA, Navrafil M. Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat [ J]. Neurology, 1997,48 (4) :921-926.
  • 9Rosenberg GA, Estrada EY, Dencoff JE. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain[ J]. Stroke, 1998,29(10) : 2189-2195.
  • 10Asahi M,Asahi K, Jung JC, et al. Role for matrix metalloproteinase 9 after focal cerebral ischemia:effects of gene knockout and enzyme inhibition with BB-94[J] .J Cereb Blood Flow Metab,2000,20(12) :1681-1689.

共引文献435

同被引文献31

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部